Literature DB >> 2022744

A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia.

F K Welty1, S T Hubl, V R Pierotti, S G Young.   

Abstract

We describe a kindred in which the proband and 6 of his 12 children have hypobetalipoproteinemia. The plasma lipoproteins of the affected subjects contained a unique species of apolipoprotein (apo) B, apo B67, in addition to the normal species, apo B100 and apo B48. The size of apo B67 and immunochemical studies with a panel of apo B-specific antibodies indicated that apo B67 was a truncated species of apo B that contained approximately the amino-terminal 3,000-3,100 amino acids of apo B100. Sequencing of genomic apo B clones revealed that affected family members were heterozygous for a mutant apo B allele containing a single nucleotide deletion in exon 26 (cDNA nucleotide 9327). This frameshift mutation is predicted to result in the synthesis of a truncated apo B containing 3,040 amino acids. Apo B67 is present in low levels in the plasma but is easily detectable within the very low density lipoprotein and low density lipoprotein fractions. Examination of the proband's immediate family revealed seven normolipidemic subjects and seven subjects with hypobetalipoproteinemia. In the affected subjects, the mean total and low density lipoprotein cholesterol levels were 120 and 42 mg/dl, respectively. A significantly higher mean high density lipoprotein cholesterol level was found in the affected subjects (75 vs. 55 mg/dl). We hypothesize that the elevated high density lipoprotein cholesterol levels in subjects heterozygous for the apo B67 mutation may be metabolically linked to the low levels of apo B-containing lipoproteins in their plasma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022744      PMCID: PMC295283          DOI: 10.1172/JCI115193

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Familial hypobeta-lipoproteinemia: studies in 13 kindreds.

Authors:  C J Glueck; P S Gartside; M J Mellies; P M Steiner
Journal:  Trans Assoc Am Physicians       Date:  1977

3.  Familial hypobetalipoproteinemia. Absence of atherosclerosis in a postmortem study.

Authors:  J A Kahn; C J Glueck
Journal:  JAMA       Date:  1978-07-07       Impact factor: 56.272

4.  Indices of relative weight and obesity.

Authors:  A Keys; F Fidanza; M J Karvonen; N Kimura; H L Taylor
Journal:  J Chronic Dis       Date:  1972-07-01

5.  Characterization of monoclonal antibodies against human low density lipoprotein.

Authors:  R W Milne; R Theolis; R B Verdery; Y L Marcel
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

6.  Characterization of human high-density lipoproteins by gradient gel electrophoresis.

Authors:  P J Blanche; E L Gong; T M Forte; A V Nichols
Journal:  Biochim Biophys Acta       Date:  1981-09-24

Review 7.  Hypolipidemia.

Authors:  M J Malloy; J P Kane
Journal:  Med Clin North Am       Date:  1982-03       Impact factor: 5.456

8.  Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies.

Authors:  L K Curtiss; T S Edgington
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  6 in total

Review 1.  Hypobetalipoproteinemia and abetalipoproteinemia.

Authors:  Francine K Welty
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

2.  An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels.

Authors:  May E Montasser; Elizabeth A O'Hare; Xiaochun Wang; Alicia D Howard; Rebecca McFarland; James A Perry; Kathleen A Ryan; Kenneth Rice; Cashell E Jaquish; Alan R Shuldiner; Michael Miller; Braxton D Mitchell; Norann A Zaghloul; Yen-Pei C Chang
Journal:  Circulation       Date:  2018-09-25       Impact factor: 29.690

Review 3.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

4.  Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo.

Authors:  K G Parhofer; P H Barrett; D M Bier; G Schonfeld
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice.

Authors:  G E Homanics; T J Smith; S H Zhang; D Lee; S G Young; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.

Authors:  Mindy C W Lam; Janakie Singham; Robert A Hegele; Maziar Riazy; Matti A Hiob; Gordon Francis; Urs P Steinbrecher
Journal:  Case Rep Gastroenterol       Date:  2012-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.